Meeting Overview - The company will hold its first extraordinary general meeting of shareholders in 2025 on September 8, 2025 [1][2] - The meeting is convened by the board of directors of Xi'an International Medical Investment Co., Ltd. [2] - The meeting complies with relevant laws and regulations, including the Company Law and the rules for listed companies [2] Meeting Details - The on-site meeting will take place at 2:45 PM on September 8, 2025, with online voting available throughout the day [3] - Shareholders can vote either in person or via the internet, but cannot use both methods for the same vote [3] - The record date for shareholders to attend the meeting is September 3, 2025 [3][4] Attendance - All shareholders registered by the record date are entitled to attend the meeting, along with the company's directors, supervisors, and legal advisors [4] - The meeting will be held at Xi'an International Medical Center Hospital [4] Agenda Items - The meeting will include several proposals, with one requiring a special resolution needing approval from over two-thirds of the voting rights present [6] - Only one director will be elected during this meeting, and cumulative voting will not apply [7] Voting Procedures - Shareholders can participate in online voting through the Shenzhen Stock Exchange trading system or internet system [12] - Voting codes and instructions for the proposals will be provided, with all proposals being non-cumulative [14][15] Registration Information - Registration for the meeting can be done in person or via fax or mail for distant shareholders [9] - The registration period is from September 4 to September 5, 2025, with the option to register on the day of the meeting [11] Additional Information - Shareholders are responsible for their own travel and accommodation expenses [18] - Contact information for inquiries is provided, including phone and fax numbers [19]

Meeting Overview - The company will hold its first extraordinary general meeting of 2025 on September 8, 2025 [1][2] - The meeting will be convened by the board of directors and is compliant with relevant laws and regulations [1][10] Meeting Details - The meeting will take place at 2:45 PM on September 8, 2025, with network voting available throughout the day [2][3] - Shareholders can vote either in person or via online platforms provided by the Shenzhen Stock Exchange [4][16] Attendance and Registration - Shareholders registered by the close of business on September 3, 2025, are eligible to attend [5][6] - Registration for attendance can be done in person or through authorized representatives [12][13] Agenda Items - The meeting will include proposals for amending the company's articles of association and electing a non-independent director [15][10] - A special resolution requires approval from at least two-thirds of the voting rights present [10][11] Voting Procedures - Voting will be conducted through both physical attendance and online systems, with specific time slots for online voting [3][18] - All proposals are non-cumulative voting items, and the first valid vote will be considered in case of duplicate votes [17][19] Additional Information - The company will not cover travel expenses for attending shareholders [20] - Contact information for inquiries is provided, including phone and fax numbers [21]

Meeting Announcement - The company will hold its first extraordinary general meeting of shareholders for 2025 on September 8, 2025, at 2:45 PM [1][2] - The meeting will comply with relevant laws and regulations, including the Company Law and the rules for listed companies [1] Voting Procedures - Shareholders can choose either on-site voting or online voting, but not both [2] - Voting will be conducted through the Shenzhen Stock Exchange trading system and an internet voting platform [1][4] Registration Details - Legal representatives of corporate shareholders must provide identification and proof of their status, while individual shareholders must present their ID and shareholding certificates for registration [3] - Remote shareholders can register via fax or mail [3] Voting Timeline - Online voting will be available on September 8, 2025, from 9:15 AM to 3:00 PM [5][13] - The voting process requires shareholders to authenticate their identity using a digital certificate or investor service password [5][13] Proposals for Voting - All proposals for the meeting are non-cumulative voting proposals, meaning shareholders express their opinions on each proposal individually [5][11] - The total proposal will be considered as a unified vote for all individual proposals [5][11]

Group 1 - The company, International Medicine (000516), announced that it will hold its first extraordinary shareholders' meeting on September 8, 2025 [1] - The agenda for the shareholders' meeting includes the proposal to amend the company's articles of association among other items [1]

证券代码：000516 证券简称：国际医学 公告编号：2025-041 西安国际医学投资股份有限公司 关于召开2025年第一次临时股东会的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 本公司于 2025 年 8 月 22 日在《证券时报》《中国证券报》《上海证券报》 《证券日报》和巨潮资讯网上发布了《关于召开 2025 年第一次临时股东会的通 知》，定于 2025 年 9 月 8 日召开 2025 年第一次临时股东会。为进一步保护投 资者的合法权益，方便本公司股东行使股东会表决权，现根据相关规定，发布 关于召开公司 2025 年第一次临时股东会的提示性公告如下： 一、会议召开的基本情况 1.股东会届次：本次股东会是 2025 年第一次临时股东会。 2.召集人：西安国际医学投资股份有限公司董事会。 3.公司第十三届董事会第六次会议审议通过了关于召开公司 2025 年第一次 临时股东会的事项。会议的召开符合《公司法》《上市公司股东会规则》《股 票上市规则》等有关法律法规、规范性文件的规定和《公司章程》的要求。 4.会议召开时间： （1）截至 2025 ...

Group 1 - The core point of the article is the announcement by International Medical regarding the pledge and release of shares by its controlling shareholder, Century New Yuan [2] - Century New Yuan released a pledge of 38,230,000 shares, which accounts for 6.21% of its holdings and 1.71% of the company's total share capital [2] - The same day, a concerted action party, Shenhua Holdings, pledged 25,310,000 shares, representing 41.84% of its holdings and 1.13% of the company's total share capital [2]

Core Points - The announcement details the release of share pledges by the controlling shareholder, Shaanxi Century New Yuan Commercial Management Co., Ltd., and its concerted party, Shenhua Holdings Group Co., Ltd. [1][2] - The release of the pledge involves 38,230,000 shares, accounting for 6.21% of the total shares held by Century New Yuan and 1.71% of the company's total share capital [1][2] - Concurrently, Shenhua Holdings has pledged 25,310,000 shares to Kaiyuan Securities Co., Ltd., which represents 41.84% of its holdings and 1.13% of the company's total share capital [1][2] Summary of Share Pledge Situations - As of the announcement date, the total pledged shares by Century New Yuan and its concerted parties are as follows: 616,061,190 shares pledged, with 502,020 shares unpledged, resulting in a pledge ratio of 32.10% [2] - The total number of shares held by Century New Yuan is 463,790,000, with a pledge ratio of 68.06% [2] - The financing amount corresponding to the pledged shares due within one year is 0.40 billion yuan [2][3] Additional Information - The company will continue to monitor the stock pledge situation of Shenhua Holdings and its concerted parties, ensuring timely disclosure of relevant information as required [3]

证券代码：000516 证券简称：国际医学 公告编号：2025-040 股东名称 是否为控股股东 或第一大股东及 其一致行动人 本次解除质押 股份数量（股） 占其所持 股份比例 占公司总 股本比例 起始日 解除 日期 质权人 世纪新元 是 38,230,000 6.21% 1.71% 2022 年 8 月 30 日 2025 年 9 月 1 日 开源证券股份有限 公司 一、控股股东本次股份解除质押的基本情况 三、控股股东及其一致行动人股份累计质押的基本情况 截至公告披露日，世纪新元及其一致行动人所持质押股份情况如下： | | | | 本次质 | 本次质 | | | 已质押股份 | | 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 押前质 | 押后质 | 占其 | 占公 | 情况 | | 情况 | | | 股东 | 持股数量 | 持股 | 押股份 | 押股份 | 所持 | 司总 | 已质押股 | 占已 | 未质押股 | 占未 | | 名称 | （股） | 比例 | 数量 | 数量 | 股 ...

Core Viewpoint - The company has experienced a decline in revenue and net profit in the first half of 2025, but has shown improvements in operational efficiency and service volume, indicating potential for recovery in the second half of the year [1][2][5]. Company Performance - In the first half of 2025, the company achieved operating revenue of 203,430.77 million yuan, a year-on-year decrease of 15.95% [2]. - The net profit attributable to shareholders was -16,496.18 million yuan, a year-on-year reduction in losses of 4.98% [2]. - The overall emergency and outpatient service volume reached 1.3191 million visits, an increase of 5.42% year-on-year [2]. - The net cash flow from operating activities was 59,254.20 million yuan, a year-on-year increase of 12.75% [2]. Hospital Operations - Xi'an Gaoxin Hospital reported emergency and outpatient visits of 578,700, a year-on-year increase of 3.04%, but inpatient visits decreased by 6.48% [3]. - Xi'an International Medical Center Hospital had emergency and outpatient visits of 740,500, a year-on-year increase of 7.37%, while inpatient visits decreased by 2.80% [3]. - Revenue for Xi'an International Medical Center Hospital was 138,327.49 million yuan, a year-on-year decrease of 15.37%, with a net profit of -11,320.98 million yuan, a decline of 44.63% [3]. Strategic Initiatives - The company is focusing on cost control through bed integration and departmental optimization, increasing the use of centralized procurement drugs and those meeting DRG payment standards [4]. - The company is developing specialty services such as health management, aesthetic medicine, physical examinations, elderly care, and international cooperation [4]. - Research in stem cells includes over 500 testing projects, with significant progress in clinical trials for mesenchymal stem cell treatments [4]. Future Outlook - For the second half of 2025, the company aims to maintain steady operations, enhance cost control, and improve efficiency while focusing on medical quality and patient service [6]. - The company plans to implement differentiated strategies to enhance added value and adapt to industry changes for orderly service expansion and improved profitability [6].

Group 1 - The company emphasizes enhancing intrinsic value and investor returns as its core objective [1] - Recently, the company has disclosed a "Market Value Management System" to improve operational management and drive high-quality development [1] - The company is the controlling shareholder of Xi'an Hancheng Lake Tourism Development Co., Ltd., holding 65% of its shares [1]